At a glance
ClinicalIndex Comparison RecordN/ACompleted· 41 enrolled
Drug / intervention
Optical Tomography Using Near Infrared Diffused Light Assisted with Ultrasounddevice
Likely dose
Not stated in record
Key inclusion· 4
- ✓Newly diagnosed locally advanced breast cancer scheduled to receive neoadjuvant chemotherapy
- ✓Clinical stage II-III ER+ HER2- breast cancer scheduled for neoadjuvant endocrine therapy (endocrine cohort)
- ✓At least 18 years of age
- ✓Female
Key exclusion· 4
- ✕Pregnant or breastfeeding
- ✕Prior history of breast cancer
- ✕Prior history of chest wall radiation
- ✕Prior history of breast reconstruction, reduction, or augmentation
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment
In Brief
A clinical study evaluating Optical Tomography Using Near Infrared Diffused Light Assisted with Ultrasound for Breast Cancer and 4 related conditions. Completed, enrolled 41 participants across 1 site.
Detailed Summary
To determine the accuracy of NIR/US assessment of tumor vasculature and oxygen changes in predicting and monitoring early neoadjuvant treatment response compared to pathological response.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer, Breast Tumors, Cancer of Breast, Cancer of the Breast, Malignant Neoplasm of Breast
CountriesUnited States
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedSep 2016
Enrollment StartNov 2016
Primary CompletionJan 2020
TodayJul 2026
First PostedSep 7, 2016
Enrollment StartNov 29, 2016
Primary CompletionJan 23, 2020
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 9.8 years ago
Interventions
Optical Tomography Using Near Infrared Diffused Light Assisted with Ultrasounddevice